Changes in Waivered Clinicians Prescribing Buprenorphine and Prescription Volume by Patient Limit-Reference-Cited by-同舟云学术

Changes in Waivered Clinicians Prescribing Buprenorphine and Prescription Volume by Patient Limit

Published:2023-05-23 Issue:20 Volume:329 Page:1792
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Luo Qian¹,Erikson Clese E.¹

Affiliation:

1. Fitzhugh Mullan Institute for Health Workforce Equity, The George Washington University, Washington, DC

Abstract

This study uses data from a Drug Enforcement Administration list of Drug Addiction Treatment Act (DATA)–waivered clinicians to examine trends in DATA-waivered clinicians’ active participation in prescribing buprenorphine overall and by patient limits between January 2017 and May 2021.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2804495/jama_luo_2023_ld_230024_1684251857.7554.pdf

Reference6 articles.

1. Beyond the waiver: multilevel interventions needed to expand buprenorphine treatment.;Samuels;JAMA Netw Open,2022

2. Changes in US clinician waivers to prescribe buprenorphine management for opioid use disorder during the COVID-19 pandemic and after relaxation of training requirements.;Spetz;JAMA Netw Open,2022

3. Buprenorphine treatment by primary care providers, psychiatrists, addiction specialists, and others.;Olfson;Health Aff (Millwood),2020

4. Buprenorphine treatment: advanced practice nurses add capacity.;Spetz;Health Aff (Millwood),2022

5. Ali? MM, Creedon? T, Jacobus-Kantor? L, ; Office of the Assistant Secretary for Planning and Evaluation. Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS buprenorphine practice guidelines. US Department of Health and Human Services. Published December 2, 2022. Accessed January 25, 2023. https://aspe.hhs.gov/reports/early-changes-after-2021-hhs-buprenorphine-practice-guidelines

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements;JAMA Network Open;2024-08-05

2. Composition of buprenorphine prescribing networks in Medicaid and association with quality of care;Journal of Substance Use and Addiction Treatment;2024-08

3. Expanding the opioid use disorder medication treatment workforce in rural communities through the RCORP initiative;The Journal of Rural Health;2024-07-25

4. Tracking 5-Year Trends in the Workforce Prescribing Psychotropics and Medications for Opioid Use Disorder: A Cross-Sectional Study;Journal of General Internal Medicine;2024-07-16

5. Knowledge, Attitudes, and Beliefs About Opioid Use Disorder Treatment in Primary Care;JAMA Network Open;2024-06-28